This altRx review covers the cheapest advertised GLP-1 program we track in 2026 — and the worst complaint record on our entire site. altRx sells compounded semaglutide for $89 per month, flat at every dose, with no membership fee on top. But behind that price sits a BBB F rating with 39 unanswered complaints, a 2.5/5 Trustpilot score, and a steady stream of customers alleging they were charged $189–$199 after signing up at $89. We scored altRx 6/10 — the lowest rating we have given any provider. Here is exactly why.

What Is altRx?

altRx is a US telehealth weight-loss clinic that sells monthly memberships for compounded GLP-1 injections. The legal entity behind it is Trinity HealthCare Supply, LLC, doing business as altRx, per the company’s own About page. Its BBB profile lists altRx, Inc at a private mailbox (PMB) address in Miami, Florida — a mailbox, not an office.

The company is very new. Its BBB file opened on May 5, 2026, meaning altRx had been on the BBB’s radar for barely ten weeks when we checked in July 2026. In that short window it collected 39 complaints that the business failed to answer.

altRx sells five products: compounded semaglutide and compounded tirzepatide injections, plus brand-name Ozempic, Wegovy, and Zepbound at cash prices of $1,149 to $1,579 per month. It ships to all 50 states, does not accept insurance, and takes FSA-eligible payments.

One more fact shapes this whole altRx review: altRx is a sister brand of Trinity Meds, operated by the same LLC and using the same four pharmacy partners. Trinity Meds carries its own troubled record — a 2.1/5 Trustpilot score with 65% one-star reviews — which we cover in our Trinity Meds review. Two budget GLP-1 brands, one operator, two poor complaint files.

altRx Pricing in 2026

On paper, altRx has the simplest and cheapest pricing in online weight loss care. There is no membership fee — the monthly price includes the telehealth consult, your care plan, prescription fulfillment, and free shipping.

Medication Advertised Price (July 2026) Listed Regular Price Notes
Compounded semaglutide $89/mo $199/mo Flat at every dose; $75/mo on a 12-month plan
Compounded tirzepatide $149/mo $299/mo Flat at every dose
Brand-name Ozempic From $1,149/mo Cash pay, no insurance
Brand-name Zepbound From $1,249/mo Cash pay, no insurance
Brand-name Wegovy From $1,579/mo Cash pay, no insurance

Notice the structure: the official site displays semaglutide as marked down — “Starting at $199/mo” struck through, “$89/mo” beside it. The site also promises “same price at every dose” and “no price hike.” If those promises held in practice, altRx would run away with our cheapest online GLP-1 providers comparison, undercutting Trinity Meds ($99) and bmiMD ($99 on a 12-month plan).

The Biggest altRx Review Complaint: $89 Advertised, $189 Charged

They do not appear to hold. BBB and Trustpilot complaints repeatedly allege the same pattern: customers sign up at the advertised $89 per month, then see charges of $189 to $199 in later billing cycles. That pattern directly contradicts the no-price-hike promise on the sales page. We cannot verify each individual complaint, but the volume and consistency of the allegations is why pricing transparency — the heaviest factor in our scoring rubric at 30% — went so badly for altRx.

The refund policy compounds the risk. No refunds are available once a prescription order is approved, processing, or shipped. Refunds exist for exactly two cases: you are found medically ineligible at the initial consult, or you document a verifiable billing error — and you must file the request within a 28-day window.

Put those two facts together. If a disputed $189 charge lands and altRx does not respond, your main recourse is a card chargeback. The 39 unanswered BBB complaints suggest how those conversations have been going.

How altRx Works

The signup flow is standard telehealth, and on this front altRx does several things right. The process runs in four steps:

  1. Assessment: a roughly 2-minute online health questionnaire. You must be 18 or older.
  2. Clinician review: a licensed provider (MD, DO, PA, or NP), credentialed through affiliated medical practices such as Usable Health, PC, reviews your answers — by live video or asynchronously, depending on your state’s law.
  3. Pharmacy: if treatment is clinically appropriate, the prescription goes to one of four named, state-licensed 503A compounding pharmacies: Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, or Casa Pharma Rx.
  4. Delivery: free shipping, arriving in about 4–5 business days.

The site states plainly that “a prescription is never guaranteed,” which is the correct and legal posture. And naming all four pharmacy partners publicly is better sourcing disclosure than several higher-scoring competitors manage.

One technical note matters, though. All four partners are 503A pharmacies, which compound patient-by-patient under lighter federal oversight than 503B outsourcing facilities. And per the FDA, compounded drugs from either category are not FDA-approved — altRx’s own disclaimer says its compounded semaglutide and tirzepatide have not been independently evaluated by the FDA for safety, efficacy, or quality.

altRx Weight Loss Results: What to Realistically Expect

No provider changes what the molecule does, so set expectations from the clinical trials, not from marketing. In the STEP 1 trial, adults taking 2.4mg semaglutide lost an average of about 14.9% of body weight over 68 weeks, alongside diet and activity changes. In SURMOUNT-1, tirzepatide produced up to about 20.9% average weight loss over 72 weeks at the highest dose. Both trials used FDA-approved brand-name medication — not compounded copies — so identical results with compounded versions are assumed, not proven.

Dosing follows the standard schedule. Semaglutide starts at 0.25mg weekly and titrates up over several months toward a 1.0–2.4mg maintenance dose; tirzepatide starts at 2.5mg weekly and can rise to 15mg. Expect the usual GLP-1 side effects — nausea, constipation, vomiting — especially during dose increases.

What do altRx customers themselves report? The documented complaint themes are about billing and support, not the medication: Trustpilot’s recent snapshot shows 2.5/5 across roughly 148 reviews, with 51% one-star ratings dominated by pricing allegations. Trustpilot also notes it removed fake reviews posted for this company — a separate red flag — while recording that altRx replies to about 67% of negative reviews. We found no reliable pattern of efficacy complaints either way, which is expected for a company this young.

altRx vs bmiMD

If the $89 price brought you here, bmiMD is the comparison that matters. It is the budget pick among providers we actually recommend, ranked #4 in our best weight loss injections guide — a ranking altRx was excluded from entirely because of its complaint record.

altRx bmiMD
Our score 6/10 (Fair) 8.2/10 (Very Good)
Semaglutide price $89/mo advertised; $75/mo on 12-month plan $129/mo monthly; $99/mo on 12-month plan
Price rises with dose? No (advertised) No
BBB record F, 39 unanswered complaints C+, 38 complaints on file
Trustpilot ~2.5/5 (~148 reviews) ~4/5 (~800 reviews)
Billing protection No refunds once order approved Card authorized, not charged, until a provider approves
Track record BBB file opened May 2026 Operating since late 2022

bmiMD costs $10 to $40 more per month depending on plan length. What that money buys is a provider whose customers mostly report being billed what they were quoted, plus a real safeguard: your card is only authorized, not charged, until a clinician approves you.

bmiMD has genuine flaws too — a C+ BBB rating, a $50 cancellation fee after intake approval, and all-sales-final terms once the pharmacy processes an order — and our bmiMD review does not gloss over any of it. But the math here is simple: a $99 plan you are actually billed $99 for is cheaper than an $89 plan that allegedly shows up as $189 on your statement.

Who Should Use altRx — and Who Shouldn’t

altRx might make sense if you understand the risk and want the lowest advertised entry price in the market. The four named 503A pharmacies, 50-state coverage, flat dose pricing, and the option to pause or cancel anytime are real positives. If you go ahead, pay with a card you monitor closely, screenshot the checkout price, and check your first three statements against it.

Skip altRx if any of the following is true: you cannot absorb a surprise $189–$199 charge; you want meaningful refund rights (there are none once an order is approved); you prefer medication from a stricter 503B outsourcing facility (all four altRx pharmacies are 503A); or you want a company with a track record longer than a BBB file opened in May 2026. That covers most shoppers.

The standard medical exclusions apply here as everywhere. GLP-1s are generally unsuitable if you have a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, a history of pancreatitis, or are pregnant or planning pregnancy. altRx requires users to be 18+ and states that a prescription is never guaranteed — a clinician should screen out anyone who does not qualify.

Is altRx Legit? Our Verdict

Legit and recommendable are two different questions. altRx is a real company: licensed clinicians review its prescriptions, its four compounding pharmacies are real and publicly named, and medication ships in 4–5 business days. This is not a fake-pharmacy scam.

But we cannot recommend it, and our 6/10 (Fair) score — the lowest on this site — reflects three documented problems. First, the BBB F rating with 39 unanswered complaints on a file open only since May 2026; an F from the BBB specifically signals a company that ignores its complaints. Second, the Trustpilot record: 2.5/5, 51% one-star, fake reviews removed by the platform, and the recurring allegation that the advertised $89 becomes $189–$199 in practice. Third, and most serious: in June 2026 the FDA sent a warning letter to Trinity HealthCare Supply, LLC — the operator of both altRx and Trinity Meds — concerning misleading compounded GLP-1 claims on the altRx website.

Where This altRx Review Lands

The frustrating part is that the bones of the offer are decent: named pharmacies, flat advertised pricing, no membership fee, all 50 states. If the company honored its advertised price, answered its BBB complaints, and stayed clear of FDA warning letters, this score would look very different.

Until that happens, treat the $89 as marketing, not a price. Pay $99–$129 at bmiMD for a cleaner billing record, or compare every provider we cover before handing over a card number. The cheapest advertised price in this market is worth nothing if it is not the price you are actually charged.